Vision Mission & Strength
R & D
Niprolac Oral Sol
Starcal D Forte
NIPRO JMI Pharma Ltd. (NJP) is contributing in developing a world-class practicein the pharma industry of Bangladesh by bridling the unment challenges in healthcare sector. It is one of the fastest growing pharmaceutical companies in Bangladesh, started its journey in 2012 with collaboration of NIPRO Corporation; a Japan based giant multinational company, a press release said.
NJP’s medicines aiding millions of diabetic, asthma patients
NIPRO JMI Pharma Limited (NJP) has introduced Linagliptin (Lijenta) and Empagliflozin (Empa), which are the breakthroughs in diabetic management and aiding millions of diabetic patients in the country....
NIPRO JMI Pharma Ltd. has celebrated Bangla New Year - 1426 at Corporate office....
Japan Bangladesh joint venture company- NIPRO JMI Pharma held its annual sales conference 2018 at International Convention City, Bashundhara, Dhaka.....
D-Star is a preparation of colecalciferol (Vitamin D3). Vitamin D3 helps for the absorption
& reabsorption of calcium & phosphorous. Vitamin D3 is essential for normal bone growth
& to maintain bone density. It also reduces the severity of bacterial infection, improves
lung function, prevents the risk of cancer (breast, colorectal) & helps to maintain adequate
insulin levels for type 2 diabetes patients.